C1INH Antibodies

Santa Cruz Biotechnology features a diverse variety of C1INH monoclonal antibodies for research focused on understanding C1 inhibitor's role in the complement and contact systems. C1INH monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). C1INH, or C1 inhibitor, is a crucial serine protease inhibitor that regulates the complement and coagulation pathways, playing a vital role in maintaining homeostasis and preventing excessive inflammation. Dysregulation of C1INH can lead to conditions such as hereditary angioedema, highlighting its significance in both health and disease. Understanding C1INH function is essential for developing therapeutic strategies for related disorders. C1INH monoclonal antibodies enable precise detection and quantification of C1INH expression levels across different tissue types and experimental conditions. Researchers can investigate C1INH's interaction with other complement components and its regulatory mechanisms in inflammatory responses. C1INH monoclonal antibodies from Santa Cruz Biotechnology support cutting-edge research that advances our understanding of complement system regulation and inflammatory diseases.